Skip to content

Clinical trials

Terminated Phase 1/2 Esophageal Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 1/2 Status: Terminated Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20101
20141
20151
20173
20181
20192
20201
20224
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated18

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
AHS Cancer Control Alberta1
Aminex Therapeutics, Inc.1
BioNTech SE1
Genmab1
Hoffmann-La Roche1
Incyte Biosciences International Sàrl1
Kymab Limited1
NextCure, Inc.1
NuCana plc1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms18
Stomach Neoplasms10
Carcinoma, Non-Small-Cell Lung7
Neoplasm Metastasis5
Endometrial Neoplasms4
Melanoma4
Neoplasms4
Squamous Cell Carcinoma of Head and Neck4
Triple Negative Breast Neoplasms4
Uterine Cervical Neoplasms4

Trials

Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.